Stocks
ICON Public Limited Company

ICON Public Limited CompanyICLR

NASDAQHealthcareBiotechnology$169.31+0.90%

Price as of · delayed, not real-time

A global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, offering clinical research and commercialization solutions. Investors monitor ICON for its exposure to the growing contract research organization (CRO) market and its role in streamlining drug development processes.

Market Cap: $7.5B52W Range: $66.57-$203.91

Congressional Interest in ICON Public Limited Company (ICLR)

8 members of Congress have disclosed 28 trades in ICON Public Limited Company (ICLR), a Healthcare company. The buy/sell breakdown shows 13 purchases versus 15 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
28
Unique Politicians
8
Buys
13
Sells
15

Who in Congress Is Trading ICLR?

2026-08-14$15K-$50K
Stock
2026-03-05$100K-$250K
Stock
2026-02-12$1K-$15K
Stock
2024-12-06$1K-$15K
Stock
2024-09-04$1K-$15K
Stock
2024-08-05$1K-$15K
Stock
2024-06-12$1K-$15K
Stock
2024-05-29$1K-$15K
Stock
2024-04-09$1K-$15K
Stock
2023-10-23$1K-$15K
Stock
2023-01-31$1K-$15K
Stock
2021-09-02$15K-$50K
Stock
2021-05-18$100K-$250K
Stock
2020-07-27$1K-$15K
Stock
2019-11-07$1K-$15K
Stock
2019-08-07$50K-$100K
Stock
2017-05-25$1K-$15K
Stock
2016-06-23$1K-$15K
Stock
2016-02-18$1K-$15K
Stock
2015-05-27$1K-$15K
Stock
2015-01-08$1K-$15K
Stock
2015-01-08$1K-$15K
Stock
2012-05-09$1K-$15K
Stock
2012-04-09$1K-$15K
Stock
2011-02-03$7,316.31
Stock
2010-06-05-$99.57
Stock
2010-06-05$990.83
Stock
2010-06-05$991.57
Stock